|
Vericel Corp.
Ticker Symbol: VCEL CUSIP: 92346J108 Previous CUSIP: 00253U305 Exchange: NCM
Company's Online Profile
BUSINESS: Vericel Corp. is a leader in advanced therapies for the sports medicine and severe burn care markets. The company markets two cell therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The company also holds an exclusive license for North American commercial rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.
|
IPO - 1/1/1900
Previous Ticker Symbol: ASTM Changed: 11/25/14
Previous Name: Aastrom Biosciences, Inc. Changed: 11/25/14
Mid Cap Stock -
Market Value $ 850 Million
Click for current VCEL price quote from the NASDAQ
Yahoo News Summary for VCEL
YAHOO! Profile for VCEL
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for VCEL
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 64 Sidney Sreet, Cambridge, MA 02139 |
| Main Phone Number |
617-252-7999 |
| Fax Number |
617-252-7550 |
| Investor Relations
Lee Stern. Solebury Trout
|
646-378-2947
|
| Toll Free Phone Number |
800-556-0311 |
| CEO - Dominick C Colangelo |
CFO - Gerard J. Michel |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
